Third-generation cephalosporin resistance of community-onset Escherichia coli and Klebsiella pneumoniae bacteremia in a secondary hospital
- PMID: 24574833
- PMCID: PMC3932395
- DOI: 10.3904/kjim.2014.29.1.49
Third-generation cephalosporin resistance of community-onset Escherichia coli and Klebsiella pneumoniae bacteremia in a secondary hospital
Abstract
Background/aims: To enable appropriate antimicrobial treatment for community-onset infections in emergency departments (EDs), data are needed on the resistance profiles of Escherichia coli and Klebsiella pneumoniae, which are the main pathogens of community-onset bacteremia.
Methods: Records were reviewed of 734 patients with E. coli and K. pneumoniae bacteremia who visited the Daegu Fatima Hospital ED, Daegu, Korea between 2003 and 2009. We investigated the demographic data, clinical findings, and antimicrobial susceptibility patterns of the organisms.
Results: Of 1,208 cases of community-onset bacteremia, 62.8% were caused by E. coli or K. pneumoniae in an ED of a secondary care hospital. Five hundred and forty-eight cases of E. coli (75%) and 183 cases of K. pneumoniae (25%) were analyzed. Urinary tract infection (43.1%) was most common, followed by intra-abdominal infection (39%) and pneumonia (7.2%). Trimethoprim/sulfamethoxazole, fluoroquinolone, third-generation cephalosporin (3GC) and amikacin resistance rates among E. coli and K. pneumoniae were 22.8%, 19.6%, 6.2%, and 1.3%, respectively. In 2009, the rate of 3GC resistance (10.6%) was significantly higher, compared to the annual averages of 2003 to 2008 (6.1%; p = 0.03). Previous exposure to antibiotics was an independent risk factor for 3GC resistance in multivariate logistic regression analysis.
Conclusions: The rate of 3GC resistance increased in community-onset infections, and previous exposure to antibiotics was an independent risk factor. Despite the increased 3GC resistance in community-onset infections, an amikacin combination therapy could provide an option for treatment of bacteremic patients with previous antibiotic exposure in an ED.
Keywords: Bacteremia; Emergency department; Escherichia coli; Klebsiella pneumonia; Secondary hospital.
Conflict of interest statement
No potential conflict of interest relevant to this article is reported.
Figures


Comment in
-
Third-generation cephalosporin resistance in gram-negative bacteria in the community: a growing public health concern.Korean J Intern Med. 2014 Jan;29(1):27-30. doi: 10.3904/kjim.2014.29.1.27. Epub 2014 Jan 2. Korean J Intern Med. 2014. PMID: 24574830 Free PMC article. No abstract available.
Similar articles
-
Comparison of antimicrobial resistances and clinical features in community-onset Escherichia coli and Klebsiella pneumoniae bacteremia.Korean J Intern Med. 2021 Mar;36(2):433-440. doi: 10.3904/kjim.2019.272. Epub 2020 Mar 31. Korean J Intern Med. 2021. PMID: 32229796 Free PMC article.
-
Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan.BMC Infect Dis. 2019 Mar 12;19(1):245. doi: 10.1186/s12879-019-3880-z. BMC Infect Dis. 2019. PMID: 30866828 Free PMC article.
-
E. coli, K. pneumoniae and K. oxytoca community-acquired infections susceptibility to cephalosporins and other antimicrobials in Lebanon.J Med Liban. 2014 Apr-Jun;62(2):107-12. doi: 10.12816/0004106. J Med Liban. 2014. PMID: 25011373
-
Community-onset Escherichia coli and Klebsiella pneumoniae bacteremia: influence of health care exposure on antimicrobial susceptibility.Diagn Microbiol Infect Dis. 2006 Jun;55(2):135-41. doi: 10.1016/j.diagmicrobio.2006.01.004. Epub 2006 Mar 9. Diagn Microbiol Infect Dis. 2006. PMID: 16529901
-
Antimicrobial Resistance as Risk Factor for Recurrent Bacteremia after Staphylococcus aureus, Escherichia coli, or Klebsiella spp. Community-Onset Bacteremia.Emerg Infect Dis. 2024 May;30(5):974-983. doi: 10.3201/eid3005.231555. Emerg Infect Dis. 2024. PMID: 38666612 Free PMC article.
Cited by
-
Potentiating aminoglycoside antibiotics to reduce their toxic side effects.PLoS One. 2020 Sep 2;15(9):e0237948. doi: 10.1371/journal.pone.0237948. eCollection 2020. PLoS One. 2020. PMID: 32877437 Free PMC article.
-
Variation in antibiotic resistance patterns for children and adults treated at 166 non-affiliated US facilities using EHR data.JAC Antimicrob Resist. 2023 Jan 2;5(1):dlac128. doi: 10.1093/jacamr/dlac128. eCollection 2023 Feb. JAC Antimicrob Resist. 2023. PMID: 36601546 Free PMC article.
-
Comparison of antimicrobial resistances and clinical features in community-onset Escherichia coli and Klebsiella pneumoniae bacteremia.Korean J Intern Med. 2021 Mar;36(2):433-440. doi: 10.3904/kjim.2019.272. Epub 2020 Mar 31. Korean J Intern Med. 2021. PMID: 32229796 Free PMC article.
-
Molecular characterization of Staphylococcus aureus isolated from hospital-acquired infections in Ilam, Iran.Mol Biol Rep. 2024 May 25;51(1):686. doi: 10.1007/s11033-024-09580-9. Mol Biol Rep. 2024. PMID: 38796602
-
From Pathophysiological Hypotheses to Case-Control Study Design: Resistance from Antibiotic Exposure in Community-Onset Infections.Antibiotics (Basel). 2022 Feb 4;11(2):201. doi: 10.3390/antibiotics11020201. Antibiotics (Basel). 2022. PMID: 35203803 Free PMC article.
References
-
- Diekema DJ, Pfaller MA, Jones RN, et al. Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997. Clin Infect Dis. 1999;29:595–607. - PubMed
-
- Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52:e103–e120. - PubMed
-
- Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:133–164. - PubMed
-
- Cheong HJ, Yoo CW, Sohn JW, Kim WJ, Kim MJ, Park SC. Bacteremia due to quinolone-resistant Escherichia coli in a teaching hospital in South Korea. Clin Infect Dis. 2001;33:48–53. - PubMed
-
- Ena J, Lopez-Perezagua MM, Martinez-Peinado C, Cia-Barrio MA, Ruiz-Lopez I. Emergence of ciprof loxacin resistance in Escherichia coli isolates after widespread use of f luoroquinolones. Diagn Microbiol Infect Dis. 1998;30:103–107. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources